Industry News

Industry News

Poorer young breast cancer patients may experience delays in seeking care

Nov 13, 2013

Researchers who sought to determine why breast cancers are more deadly in young women found that only a minority of young women experience long delays between the time they detect a breast abnormality and the time they receive a diagnosis, but delays in seeking care are more common in women with fewer financial resources... Read More

Epigenetic silencing of the HAND2 tumor suppressor promotes endometrial cancer

Nov 12, 2013

A study published in PLOS Medicine suggests that epigenetic modification of the HAND2 gene plays a critical role in the development of endometrial cancer. HAND2 is active in the healthy endometrium (the tissue lining the uterus) where it antagonizes the growth-inducing effects of estrogen... Read More

Breast cancer radiotherapy during surgery could ease treatment

Nov 12, 2013

Two new studies published in leading journals this week show how a "one-stop" targeted radiotherapy given during lumpectomy may offer some patients with early-stage breast cancer a viable alternative to current treatments. Experts say the approach looks promising but more research is needed to identify which patients are most likely to benefit... Read More

Multi-site study further demonstrate efficacy and quality of life benefits for prostate cancer patients treated with Accuray's Cyberknife® System

Nov 12, 2013

Accuray Incorporated (Nasdaq: ARAY), has announced the publication of two papers stemming from a large multi-center study of CyberKnife® stereotactic body radiotherapy (SBRT) led by investigators at the University of California, Los Angeles(UCLA)... Read More

Study finds new explanation for resistance to breast cancer treatment

Nov 12, 2013

Breast cancers that initially respond to hormone therapies such as tamoxifen eventually become resistant to treatment, and a new study finds this may be because of a mutation in the receptor present in the cancer cell to which tamoxifen binds, according to data published in Cancer Research, a journal of the American Association for Cancer Research... Read More

Simple blood test for sub-type specific lung cancer diagnosis

Nov 12, 2013

Lung cancer is the leading cause of cancer specific death worldwide. 85% lung cancers are non-small cell lung cancers (NSCLC) while remaining are small cell lung cancers (SCLC). Although X-Ray and CT scan remain the main non-invasive diagnosis strategy, the painful lung tissue biopsy is essential for confirmation and staging of the disease... Read More

Histone demethylase associated with non-small cell lung cancer identified

Nov 12, 2013

Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer deaths worldwide. Current therapies that target cellular kinases have been effective for some patients: however, many individuals with NSCLS do not respond. Recent studies of other cancers indicate that the global changes in DNA methylation patterns may drive tumor formation... Read More

TWEAK-Fn14 a key drug target for glioblastoma and other cancers

Nov 12, 2013

A cellular pathway interaction known as TWEAK-Fn14, often associated with repair of acute injuries, also is a viable target for drug therapy that could prevent the spread of cancer, especially brain cancer, according to a study led by the Translational Genomics Research Institute (TGen)... Read More

Potential drug target may nip cancer in the bud

Nov 12, 2013

Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, as a potential target to weed out the progression of cancer. Although studies in the past have revealed that this enzyme plays a critical role in regulating the budding of tumours, scientists have for the first time unearthed a mechanism for its mode of action... Read More

Discovery of racial difference in blood clotting warrants a closer look at heart attack medications

Nov 12, 2013

Thomas Jefferson University researchers have discovered that the formation of blood clots follows a different molecular route in African Americans versus European Americans, providing a new understanding of the effects of race on heart disease... Read More

Previous Page   Next Page